Biomea Fusion, Inc. (BMEA)

NASDAQ

$0.75

$-0.01

(-1.71%)

Pre-Market

Biomea Fusion, Inc. (BMEA) Live Price Chart

Last updated: ⁦2026-10-21 12:29:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Biomea Fusion, Inc. (BMEA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.75, with a market capitalization of $60.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.74 to $2.24. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$60.56M
Open	$0.76
Day's High	$43.69
Day's Low	$0.74
Previous Close	$0.74
Volume	34.96K
Average Volume	2.03M
P/E Ratio	--
52-Week High	$2.24
52-Week Low	$0.74
Dividend Yield	--
Earnings Date	--

Biomea Fusion, Inc. (BMEA) Pre-Market Stock Price

Biomea Fusion, Inc. (BMEA) is trading at $0.75 in pre-market trading as of 2026-10-21 12:25:00, up 1.41% ($0.01) from the previous close of $0.74

Pre-market trading shows how investors are pricing BMEA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Biomea Fusion, Inc. (BMEA) 7-Day Stock Price Change

Over the past seven days, Biomea Fusion, Inc. (BMEA) moved from $1.36 to $0.75, representing a decline of 45.15% ($0.61).

The stock traded between $0.74 and $1.46 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 5.35 million shares, up versus the previous seven-day period, indicating higher trading activity.

BMEA 52-Week Price Position

Position in Range: 0.7%

52W Low$0.74

52W High$2.24

BMEA is currently trading at $0.75, placing it 0.7% of the way from its 52-week low of $0.74 to its 52-week high of $2.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Biomea Fusion, Inc. (BMEA)?

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Biomea Fusion, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	37
Exchange	NASDAQ
Company Website	https://www.biomeafusion.com

How to Buy Biomea Fusion, Inc. (BMEA) Stock on MEXC

Eligible investors can buy real shares of Biomea Fusion, Inc. (BMEA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BMEA and Place Your Order

Open the RealStocks trading page and search for BMEA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Biomea Fusion, Inc. (BMEA) stock price today?

Biomea Fusion, Inc. (BMEA) is currently trading at $ 0.75, up 1.41% ($0.01) from the previous close of $ 0.74. Intraday prices update in real time during regular trading hours.

2.Is BMEA stock going up or down today?

As of 2026-10-21 12:25:00, BMEA is trading at $ 0.75, up 1.41% ($0.01) from its previous close of $ 0.74. The stock has traded between $ 0.74 and $ 43.69 during today’s regular session. Past price movements do not guarantee future results.

3.What is BMEA pre-market price?

As of 2026-10-21 12:25:00, BMEA is trading at $ 0.75 in pre-market trading, up 1.41% ($0.01) from the previous close of $ 0.74. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BMEA after-hours price?

As of 2026-10-21 12:25:00, BMEA is trading at $ 0.76 in after-hours trading, up 3.32% ($0.02) from the regular-session close of $ 0.74. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BMEA stock trading now?

BMEA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BMEA sit relative to its 52-week high and low?

Over the past 52 weeks, BMEA has traded between a low of $ 0.74 and a high of $ 2.24. At $ 0.75, the stock is positioned 0.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Biomea Fusion, Inc. in?

Biomea Fusion, Inc. (BMEA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Biomea Fusion, Inc.'s market capitalization and where is it listed?

Biomea Fusion, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 60.56M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BMEA valued in terms of P/E ratio and EPS?

BMEA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.45. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Biomea Fusion, Inc. pay a dividend?

Biomea Fusion, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.